Bonito Biosciences

Waltham, United States

Bonito Biosciences is a biotechnology research firm specializing in tissue-selective drug delivery for oligonucleotides and macromolecules.

$9.0M raised

May 2024

Seed

Biotechnology Medical Product Research

Top Investors

Lightstone Ventures Anterra Capital Jazz Venture Partners

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Bonito Biosciences

How much funding has Bonito Biosciences raised?

Bonito Biosciences has raised $9.0M in total funding. The most recent round was Seed. The last funding was announced in May 2024.

Who are Bonito Biosciences's investors?

Bonito Biosciences's investors include Lightstone Ventures, Anterra Capital, Jazz Venture Partners.

Where is Bonito Biosciences headquartered?

Bonito Biosciences is headquartered in Waltham, United States.

What does Bonito Biosciences do?

Bonito Biosciences is a biotechnology research firm specializing in tissue-selective drug delivery for oligonucleotides and macromolecules.

What stage is Bonito Biosciences at?

Bonito Biosciences is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 31, 2024.

MLA

"Bonito Biosciences — Funding & Investors." VCBacked, May 31, 2024, https://www.vcbacked.co/company/bonito-biosciences. Accessed July 2, 2026.

APA

VCBacked. (2024). Bonito Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/bonito-biosciences

Wikipedia (cite web)

{{cite web |title=Bonito Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/bonito-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 31, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K